Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib

Dermatol Ther. 2022 Nov;35(11):e15802. doi: 10.1111/dth.15802. Epub 2022 Sep 15.

Authors

Dong Heon Lee¹, So Yun Park¹, Narang Hong¹, Hyung Don Kook¹, Hye Jung Jung¹, Mi Youn Park¹, Jiyoung Ahn¹

Affiliation

¹ Department of Dermatology, National Medical Center, Seoul, Republic of Korea.

PMID: 36043599
DOI: 10.1111/dth.15802

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Azetidines* / therapeutic use
Dermatitis, Atopic* / diagnosis
Dermatitis, Atopic* / drug therapy
Humans
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
baricitinib
Antibodies, Monoclonal, Humanized
Azetidines